Compliance and cancer chemotherapy
Compliance with drug treatment is a problem in many branches of medicine but is not widely recognised as such in clinical oncology. Lewis et al have recently sought to broaden the concept of compliance from the traditional one of adherence by the patient to a prescribed oral regimen.' They cited the doctor's behaviour, the doctor-patient relationship, and the degree of psychosocial support available to the patient as important factors in determining how much of the intended dose was actually taken, and reviewed the data on the effect of these reductions in dose on outcome. Assessment of individual compliance is limited by the lack of a simple urine test for most anticancer drugs and complicated by the frequent use of multidrug treatments. One study used assay of urinary 17-ketogenic steroids to determine compliance with treatment with prednisone in 52 patients with acute leukaemia. Some 30°o were found to be noncompliant, and this figure rose to 60°in the adolescent subgroup.2 Most other studies of compliance in patients with cancer have used the less reliable questionnaire approach.
Nausea and vomiting are probably the most frequent symptoms contributing to non-compliance, and there have been several recent attempts to refine antiemetic treatment.3 The control of severe "central" nausea and vomiting is still, however, far from perfect, and treatment will continue to cause many patients substantial distress.
The extent to which physicians' attitudes to adherence to the prescribed dose affect the doses actually administered has been studied in several multicentre trials. In the Medical Research Council study on advanced ovarian cancer, the protocol was substantially modified or abandoned as a result of toxicity in 44() ' , of 130 patients in the combination chemotherapy arm compared with only 14",, of 131 patients in the oral single agent arm.4 To these figures should be added the extent of non-compliance by the patient which could not be assessed in that study. A review of the National Surgical Adjuvant Breast Project study showed that about 30" of the patients failed to complete the two years of treatment. Furthermore, the variation in the incidence of gastrointestinal toxicity from institution to institution suggested substantial differences in the recognition of patients' complaints or the emphasis given to them.5
Two studies from major cancer centres have looked at the effects on outcome of the reduction in dose by physicians. Bonnadonna and Valagussa analysed the reductions in dose in 238 patients given adjuvant combination chemotherapy for breast cancer.6 The five year survival of those who received more than 85(,, of the intended dose was 77") compared with 45( for those who received less than this dose level (p<0.0001). There was no observed relation between age and the reduction in dose due to toxicity. A more recent study from Stanford applied complex statistical analysis to data on 123 patients with Hodgkin's disease.7 The rate of drug delivery during the first three cycles of combination chemotherapy was found to be important in achieving a complete response. The rate of delivery of nitrogen mustard was the third most significant variable in predicting increased survival, after age and pleural disease.
In the past few years doctors have, rightly, become increasingly concerned about the quality of life for patients receiving cancer chemotherapy. Once the decision to treat has been taken, however, and the aim clearly defined as cure or palliation, undue concern for safety or acceptability should not be allowed to obscure the principal goal of efficacy. Review of the original decision or modification of the dose may be indicated more frequently in cases where treatment is given with palliative rather than curative intent. In human tumours neither the relation of dose to response nor its relation to toxicity is well understood, and reductions in dose have to be based on early toxicity assessed weeks, months, or years before any beneficial effect may be measured. Without doubt, however, the low therapeutic ratio of cancer treatments results in considerable variations in the way doctors and patients carry out a treatment policy-though most would accept the convention that in cancer treatment should usually be pushed to the limits of toxicity.8 In order that these limits may be more clearly defined, doctors who treat patients with cancer should be prepared to document the extent of and reasons for deviations from the particular treatment policy being followed. They should also be in a position to evaluate the defined end points of that treatment-usually response, interval free of disease, and survival-in terms of the treatment actually given and the toxicity encountered. At the press conference to launch the group, held after the BMJ had gone to press, Professor Strong was due to recite the all too familiar list of medical, family, and social problems that are linked with alcohol. As many as a million individuals in Britain suffer serious problems because of their drinking, and their problems inevitably affect the many millions who are their husbands, wives, children, parents, employers, and friends. Each year, as Professor Strong will say, the deaths of 500 people under 25 (10%O of all such deaths) result through drunkenness. In 1980 half a million admissions to general medical hospitals were linked with alcohol, while in 1979 almost 14 000 admissions to psychiatric hospitals were for "alcoholism" and "alcoholic psychosis." Alcohol is also associated with 8002 of deaths from fire, 650/ of serious head injuries, half of all murders, 400" of road traffic accidents that include pedestrians, 350, of fatal accidents, a third of all domestic accidents, and 14)', of drownings. A third of divorce petitions cite alcohol as a contributory factor, and in a third of all child abuse cases one parent drinks heavily. Eight million working days are lost a year through drink problems, and a conservative estimate by the Department of Health and Social Security2 put the total annual cost for alcohol abuse through lost productivity, accidents, and the costs of treatment and social services at L650m for 1977-8-the real figure for 1982 must be several times higher.3
One of the main jobs of Action on Alcohol Abuse will be to recite this list continually into the ears of ministers, civil servants, members of Parliament, and trade unionists. Nobody in the 16 government departments that have something to do with alcohol should be allowed to forget the terrible problems that can result from this pleasurable and profitable liquid. Political action, such as increasing tax on alcohol and curbing advertising, is no panacea for alcohol problems, but as the Royal College of Psychiatrists,4 the World Health Organisation's expert committee,5 and the government's own much suppressed and now extinct think tank6 have argued, the political response is at least as important, and probably more important, than the medical or social one. A study that we publish today (p 809) confirms that price increases can decrease alcohol consumption and problems not only in moderate drinkers but also in heavy and possibly dependent drinkers. Action on Alcohol Abuse should pressurise the government to take up the recommendation of the think tank and establish an advisory council on alcohol policies with connections with all government departments. This would be an essential step on the road to the government having a long term comprehensive programme to reduce alcohol abuse. The government should also be encouraged to publish the think tank report on alcohol policies; this would help to raise the quality of the political debate, save everybody the trouble and cost of ordering their copies from Sweden, and bring into the government funds that belong to it and not Stockholm University.
The argument, we suspect, that will carry most weight with this particular government is the economic one. Although to the government alcohol means an income of £4500m from excise duties and VAT, £900m in exports, and three quarters of a million jobs, it also results in enormous costs. A higher tax might well increase government income as well as reduce alcohol consumption, and so reduce damage and costs. Action on Alcohol Abuse should investigate the economic arguments and present the government with a sound strategy for saving money as well as lives. But at the same time it must discourage the government and the drink trade from pushing exports to Third World countries-Britain's awful problems should not be exported to countries which have quite enough of their own.
Much of Action on Alcohol Abuse's work will be with the media, and it will find that they are much more interested in "booze" than they are in "fags." The message on limiting consumption and drinking more sensibly is more complicated than the one not to smoke, and the one trap that Action on Alcohol Abuse must avoid is to be seen as a temperance organisation. The alcohol lobby will try its hardest to label it as a killjoy group, and, although it would be unthinkable for the director of Action on Smoking and Health to be seen smoking a cigarette, the director of Action on Alcohol Abuse should be seen occasionally with a glass in his hand. The quality of the director will, of course, largely make or break Action on Alcohol Abuse, and we are sure that the board of management will take great care with its appointment: experience of campaigning will, we believe, be a much better qualification than an exhaustive knowledge of alcohol problems.
The importance of the birth of Action on Alcohol Abuse is much increased by the disgraceful disarray that has been allowed to arise over the replacement of the present voluntary organisations concerned with alcohol problems with a new single body. A Department of Health and Social Security study group recommended this replacement more than a year ago,7 and Mr Kenneth Clarke, the Minister of Health, said in October 1982 that he would like to see the new body established by April 1983.8 Through bureaucratic bungling or procrastination (it is hard to tell which, and the details are too tedious to relate), this new body is unlikely to appear before April 1984. Meanwhile the confused existing organisations are continuing on extended grants. It is scandalous that the government has fiddled in this way while alcohol problems
